X-Chem
Waltham, MA, United States x-chemrx.com From their website, Nov 2026
Work here? Claim this listing
About
X-Chem is a drug discovery partner that works with biotech, pharma, and academic teams. It focuses on DNA-encoded library (DEL) screening, medicinal and synthetic chemistry, computational sciences, and related discovery services from early hit finding through candidate nomination. It has sites in Waltham, Massachusetts; Montreal, Quebec; and Budapest, Hungary.
Services
DEL Screening
Uses DNA-encoded library screening to identify hits and new chemical matter for difficult targets and modalities.
Chemomics
Transforms DEL data into actionable discovery decisions through data-driven analysis and interpretation.
HitBuilder
Milestone-driven hit-finding program that supports early discovery and prioritization.
LeadBuilder
Milestone-driven lead optimization program that advances series toward stronger candidates.
CandidateBuilder
Program for candidate nomination and progression from optimized leads to candidate selection.
Fee for Service Packages
Modular project-based services that can combine DEL screening, chemistry support, computational modeling, AI tools, and scientific advisory support.
Platform Enablement
Provides DELenable, including ready-to-run libraries, protocols, informatics, training, and support for internal DEL screening.
Medicinal & Synthetic Chemistry
Provides medicinal chemistry, synthetic chemistry, design-test cycles, analog generation, SAR exploration, and optimization support.
5 more services
- Research Products
- Computational Sciences
- Strategic Collaborations
- Medicinal & Synthetic Chemistry Research
- Scientific Advisory
- What to send
- Tag-chemistry keys
- Aliquots
- ReadiDELs
- Proteins for affinity or multiplexed screens
Capabilities
- Assays and studies
- Small molecules
- DEL screening
- Affinity screens
- Multiplexed screens
- Screening
- Validation
- SAR analysis
- Computational modeling
- Scale and capacity
- 40+ curated libraries totaling over 15 billion compounds
- 640+ DEL-compatible building blocks
- Sufficient aliquots for ~1,000 conditions
- Thousands of screening conditions
- 100+ licensed discovery programs worldwide
- ~1,000 conditions
- 0 + Novel Series Programs
- 18 clinical candidates
- Therapeutic areas
- Oncology
- Inflammation
- Neurological diseases
- Dementia
- Spinal muscular atrophy
Instruments and platforms
- ELN
- LIMS
Modalities and species
- Modalities
- Small molecule
- Peptide
- Species and models
- HeLa
- E3 ligase
- KEAP1
- DCAF
Industries served
- Biotech
- Pharma
- Academic centers
- Drug discovery
Company
- Type
- CRO
- Founded
- 2016
Locations
- Address
- 100 Beaver Street Waltham, MA 02453 United States
- Sites
- Montreal, Canada
- Budapest, Hungary
- Serves
- North America, Europe, global
Contacts
- Phone
- +1 781.419.6900